If you have not yet done so, please view the full Submission Guidelines.

Please enter the requested information for the discussion leader and discussion topic. Roundtables will be presented onsite at the conference during the luncheon on Day Two. All roundtable leaders must be registered for the DIA/FDA Oligonucleotide-Based Therapeutics Conference.

Please save your own copy of your title and abstract as this form has no way to automatically email it to you upon completion.

Questions with asterisks are required.

The submission deadline is July 19, 2024.

Notification letters are anticipated to be sent the week of August 19, 2024.
( Privacy & Cookie Notice

T